FDANonrulemakingFDA-2021-N-0891

Who commented on this docket

Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments

14 organizations filed 14 public comments on Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments, at the Food and Drug Administration. The comment window closed 1734d ago.

Organizations
14
Comments
14
RIN
Comment window
closed 1734d ago

Commenters (14)

  • a center of the Milken Institutetrade assoc.
    1 filing · confidence 85%
  • Alliance for Aging Researchtrade assoc.
    1 filing · confidence 85%
  • Alliance for Regenerative Medicine - Washingtontrade assoc.
    1 filing · confidence 85%
  • American Society of Gene & Cell Therapytrade assoc.
    1 filing · confidence 85%
  • EveryLife Foundation for Rare Diseasestrade assoc.
    1 filing · confidence 85%
  • LUNGevity Foundationtrade assoc.
    1 filing · confidence 85%
  • Lupus Foundation of Americatrade assoc.
    1 filing · confidence 85%
  • Muscular Dystrophy Associationtrade assoc.
    1 filing · confidence 85%
  • National Alliance for Caregivingtrade assoc.
    1 filing · confidence 85%
  • Personalized Medicine Coalitiontrade assoc.
    1 filing · confidence 85%
  • Physicians Committee for Responsible Medicinetrade assoc.
    1 filing · confidence 85%
  • The RWE Alliancetrade assoc.
    1 filing · confidence 85%
  • Vizient Inc.unverified attribution
    1 filing · confidence 70%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.